Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Victoria Pelak

Concepts (236)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Alzheimer Disease
10
2024
478
3.200
Why?
Vision Disorders
13
2023
130
2.830
Why?
Neurodegenerative Diseases
4
2022
98
2.060
Why?
Eye Movements
3
2021
52
1.350
Why?
Atrophy
6
2024
158
1.340
Why?
Cerebral Cortex
6
2022
395
1.240
Why?
Cerebral Amyloid Angiopathy
1
2024
10
0.950
Why?
Eye Diseases
2
2020
75
0.940
Why?
Lewy Body Disease
2
2020
16
0.880
Why?
Cognitive Dysfunction
3
2023
294
0.870
Why?
Tremor
2
2021
44
0.820
Why?
Nervous System Diseases
2
2020
255
0.800
Why?
Posterior Leukoencephalopathy Syndrome
1
2021
9
0.800
Why?
Ocular Motility Disorders
4
2018
25
0.790
Why?
Visual Perception
2
2022
139
0.780
Why?
Fragile X Syndrome
1
2021
75
0.770
Why?
Macular Degeneration
1
2022
151
0.730
Why?
Reading
1
2021
152
0.720
Why?
Mucolipidoses
1
2019
7
0.700
Why?
Tomography, Optical Coherence
4
2022
125
0.700
Why?
Visual Pathways
3
2018
43
0.680
Why?
Dementia
2
2011
187
0.640
Why?
Pneumonia, Viral
2
2020
345
0.640
Why?
Coronavirus Infections
2
2020
338
0.640
Why?
Betacoronavirus
2
2020
254
0.630
Why?
Ophthalmology
1
2018
76
0.600
Why?
Visual Fields
5
2022
76
0.600
Why?
Migraine Disorders
1
2018
81
0.590
Why?
Neurology
1
2018
88
0.590
Why?
Androgens
1
2016
167
0.510
Why?
Aging
3
2023
1663
0.490
Why?
Magnetic Resonance Imaging
10
2024
3124
0.480
Why?
Optic Neuropathy, Ischemic
3
2012
30
0.460
Why?
Testosterone
1
2016
348
0.440
Why?
Pandemics
2
2020
1348
0.440
Why?
Humans
47
2024
117613
0.420
Why?
Cognition
2
2023
1005
0.370
Why?
Inflammation
1
2020
2526
0.350
Why?
Optic Nerve Diseases
2
2009
31
0.350
Why?
Optic Neuritis
3
2020
37
0.350
Why?
Myelin-Oligodendrocyte Glycoprotein
2
2020
43
0.350
Why?
Vision, Low
1
2009
14
0.340
Why?
Optic Nerve
1
2009
63
0.330
Why?
Giant Cell Arteritis
3
2020
48
0.300
Why?
Brain Diseases
2
2017
128
0.300
Why?
Congresses as Topic
2
2019
204
0.290
Why?
Visual Acuity
6
2022
267
0.280
Why?
Cataract Extraction
1
2006
76
0.260
Why?
Male
23
2024
56905
0.250
Why?
Nerve Net
2
2022
227
0.250
Why?
Pseudotumor Cerebri
2
2016
22
0.240
Why?
Aged
11
2023
19482
0.240
Why?
Cognition Disorders
2
2023
494
0.240
Why?
Cerebral Hemorrhage
1
2024
98
0.220
Why?
Middle Aged
17
2024
27300
0.220
Why?
Cognitive Aging
1
2023
14
0.220
Why?
Immunosuppressive Agents
4
2020
675
0.210
Why?
Lewy Bodies
1
2022
3
0.210
Why?
Unconsciousness
1
2022
23
0.210
Why?
Neuropsychological Tests
3
2022
961
0.210
Why?
Ataxia
1
2021
36
0.200
Why?
Amnesia
2
2012
44
0.200
Why?
White Matter
1
2023
103
0.200
Why?
Female
22
2024
60914
0.200
Why?
Diffusion Tensor Imaging
2
2023
66
0.200
Why?
Retinal Ganglion Cells
1
2022
92
0.200
Why?
Trochlear Nerve Diseases
1
2001
6
0.200
Why?
Fragile X Mental Retardation Protein
1
2021
61
0.200
Why?
Oculomotor Nerve Diseases
1
2001
9
0.190
Why?
Abducens Nerve Diseases
1
2001
10
0.190
Why?
Stents
2
2016
469
0.190
Why?
Myasthenia Gravis
1
2020
18
0.190
Why?
Brain
6
2023
2391
0.180
Why?
Autonomic Fibers, Preganglionic
1
1999
4
0.180
Why?
Siderosis
1
1999
3
0.180
Why?
Pupil
1
1999
13
0.180
Why?
Eye Movement Measurements
1
2019
10
0.180
Why?
Immunomodulation
1
2020
89
0.180
Why?
Retrospective Studies
7
2024
12905
0.180
Why?
West Nile Fever
1
2020
51
0.170
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2020
142
0.170
Why?
Brain Stem
1
2000
102
0.170
Why?
Hearing Loss
1
2023
183
0.170
Why?
Diagnostic Techniques, Ophthalmological
1
2019
36
0.170
Why?
Steroids
1
2020
153
0.170
Why?
Immune System
1
2020
178
0.160
Why?
Facial Recognition
1
2019
28
0.160
Why?
San Francisco
1
2018
56
0.160
Why?
Facial Expression
1
2019
60
0.160
Why?
Frontotemporal Dementia
1
2019
35
0.160
Why?
Transcranial Magnetic Stimulation
1
2018
43
0.160
Why?
Vestibule, Labyrinth
1
2018
53
0.150
Why?
Epilepsy, Temporal Lobe
1
2017
20
0.150
Why?
Critical Care
1
2021
481
0.150
Why?
Transverse Sinuses
1
2016
8
0.150
Why?
Adult
13
2022
31154
0.140
Why?
Papilledema
2
2018
36
0.140
Why?
Immunotherapy
1
2020
492
0.140
Why?
Universities
1
2018
340
0.140
Why?
Case-Control Studies
2
2021
3121
0.140
Why?
Postoperative Complications
1
2006
2203
0.130
Why?
Laser Therapy
1
2017
101
0.130
Why?
Amygdala
1
2017
172
0.130
Why?
Brain Mapping
3
2022
520
0.120
Why?
Clinical Trials as Topic
1
2019
958
0.120
Why?
Parkinson Disease
1
2018
334
0.120
Why?
Biomarkers
2
2024
3562
0.110
Why?
Diffusion Magnetic Resonance Imaging
2
2023
86
0.110
Why?
Biomedical Research
1
2019
601
0.110
Why?
Multiple Sclerosis
3
2020
382
0.110
Why?
Hippocampus
1
2017
709
0.110
Why?
Autoantibodies
2
2018
1330
0.110
Why?
Optic Disk Drusen
1
2012
5
0.110
Why?
Visual Field Tests
1
2011
13
0.100
Why?
Cranial Sinuses
1
2011
13
0.100
Why?
Optic Disk
2
2009
36
0.100
Why?
Hemodynamics
1
2016
987
0.100
Why?
Hemianopsia
1
2011
9
0.100
Why?
Memory, Episodic
1
2012
40
0.100
Why?
Quality of Life
1
2022
2381
0.100
Why?
Diagnosis, Differential
3
2009
1346
0.090
Why?
Neurosurgical Procedures
1
2011
163
0.090
Why?
Nervous System Malformations
1
2009
34
0.080
Why?
Hypokinesia
1
2008
7
0.080
Why?
Stiff-Person Syndrome
1
2008
7
0.080
Why?
Age of Onset
2
2020
457
0.080
Why?
Rest
2
2022
103
0.070
Why?
Arteritis
1
2006
27
0.070
Why?
Spinal Nerve Roots
1
2005
30
0.070
Why?
Cranial Nerve Diseases
1
2005
41
0.060
Why?
Animals
4
2023
32774
0.060
Why?
Peripheral Nervous System Diseases
1
2005
121
0.060
Why?
Predictive Value of Tests
1
2009
1838
0.060
Why?
Blindness, Cortical
1
2003
5
0.060
Why?
Adolescent
6
2020
18254
0.060
Why?
Gliosis
1
2023
34
0.060
Why?
Neurites
1
2023
44
0.060
Why?
Demography
1
2024
273
0.060
Why?
Young Adult
4
2022
10721
0.050
Why?
Follow-Up Studies
3
2017
4528
0.050
Why?
Pulvinar
1
2022
4
0.050
Why?
Amyloid beta-Peptides
1
2024
197
0.050
Why?
Diplopia
1
2001
16
0.050
Why?
Pre-Eclampsia
1
2003
185
0.050
Why?
Neuroimaging
1
2023
252
0.050
Why?
Connectome
1
2022
63
0.050
Why?
Functional Laterality
1
2022
200
0.050
Why?
Strabismus
1
2001
26
0.050
Why?
Treatment Failure
2
2016
339
0.050
Why?
Cohort Studies
2
2024
5057
0.050
Why?
Vision Tests
1
2000
15
0.050
Why?
Vision, Ocular
1
2000
31
0.050
Why?
Immunization, Passive
1
2020
79
0.050
Why?
Temporal Lobe
2
2012
86
0.050
Why?
Demyelinating Diseases
1
2020
76
0.040
Why?
New Orleans
1
2019
12
0.040
Why?
Eye Pain
1
2018
7
0.040
Why?
Fluorescent Antibody Technique, Indirect
1
2018
52
0.040
Why?
Encephalitis
1
2020
127
0.040
Why?
Antirheumatic Agents
1
2020
255
0.040
Why?
Recurrence
1
2020
969
0.040
Why?
Focus Groups
1
2018
385
0.030
Why?
Transfection
1
2018
877
0.030
Why?
HEK293 Cells
1
2018
626
0.030
Why?
Child, Preschool
2
2020
9340
0.030
Why?
Hospital Mortality
1
1999
798
0.030
Why?
Flow Cytometry
1
2018
1066
0.030
Why?
Patient Participation
1
2018
369
0.030
Why?
Immunoglobulin G
1
2018
788
0.030
Why?
Emotions
1
2019
488
0.030
Why?
Child
3
2020
18921
0.030
Why?
Qualitative Research
1
2018
961
0.030
Why?
Disease Management
1
2016
560
0.030
Why?
Colorado
1
2022
4144
0.030
Why?
Color Vision Defects
1
2012
6
0.030
Why?
Spinal Puncture
1
2012
16
0.030
Why?
Phlebography
1
2011
40
0.030
Why?
Cerebral Angiography
1
2011
114
0.020
Why?
Lymphokines
1
1991
120
0.020
Why?
Stroke
1
1999
1027
0.020
Why?
Surveys and Questionnaires
1
2022
4689
0.020
Why?
Hospitalization
1
1999
1772
0.020
Why?
Phenotype
1
2018
2894
0.020
Why?
Autoradiography
1
1989
72
0.020
Why?
Analysis of Variance
1
2012
1248
0.020
Why?
Supranuclear Palsy, Progressive
1
2008
6
0.020
Why?
T-Lymphocyte Subsets
1
1991
392
0.020
Why?
Macaca mulatta
1
1989
135
0.020
Why?
Brain Chemistry
1
1989
115
0.020
Why?
Blindness
1
2008
37
0.020
Why?
Saccades
1
2008
39
0.020
Why?
Oculomotor Muscles
1
2008
41
0.020
Why?
Withholding Treatment
1
2008
67
0.020
Why?
Killer Cells, Natural
1
1991
380
0.020
Why?
Glutamate Decarboxylase
1
2008
159
0.020
Why?
Frontal Lobe
1
1989
139
0.020
Why?
Immunoglobulins, Intravenous
1
2008
126
0.020
Why?
gamma-Aminobutyric Acid
1
2008
153
0.020
Why?
Neural Inhibition
1
2008
151
0.020
Why?
Pilot Projects
1
2012
1400
0.020
Why?
Lymphocyte Activation
1
1991
1064
0.020
Why?
Receptors, Antigen, T-Cell
1
1991
636
0.020
Why?
Sensitivity and Specificity
1
2011
1754
0.020
Why?
Electromyography
1
2008
327
0.020
Why?
Treatment Outcome
2
2011
9296
0.020
Why?
Cranial Nerves
1
2005
11
0.020
Why?
Sural Nerve
1
2005
19
0.020
Why?
Nerve Fibers, Myelinated
1
2005
40
0.020
Why?
Graves Disease
1
2005
32
0.020
Why?
Hypertrophy
1
2005
122
0.020
Why?
Amino Acids
1
1989
463
0.020
Why?
Reproducibility of Results
1
2011
2837
0.010
Why?
Mice
1
2020
15309
0.010
Why?
Myelin Sheath
1
2005
146
0.010
Why?
Axons
1
2005
182
0.010
Why?
Disease Progression
1
2008
2470
0.010
Why?
Contrast Sensitivity
1
2000
12
0.010
Why?
Observer Variation
1
2000
308
0.010
Why?
Muscle, Skeletal
1
2008
1502
0.010
Why?
Reference Values
1
2000
757
0.010
Why?
Walking
1
2000
423
0.010
Why?
Tomography, X-Ray Computed
1
2003
2401
0.010
Why?
Age Factors
1
1999
2961
0.010
Why?
Pregnancy
1
2003
5709
0.010
Why?
Antigens, Differentiation, T-Lymphocyte
1
1991
84
0.010
Why?
Blotting, Northern
1
1991
192
0.010
Why?
Antigens, Differentiation
1
1991
79
0.010
Why?
Receptors, IgG
1
1991
66
0.010
Why?
CD3 Complex
1
1991
93
0.010
Why?
Receptors, Fc
1
1991
47
0.010
Why?
Receptors, Antigen, T-Cell, gamma-delta
1
1991
102
0.010
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
1991
311
0.010
Why?
Base Sequence
1
1991
2125
0.000
Why?
Molecular Sequence Data
1
1991
2820
0.000
Why?
Gene Expression
1
1991
1468
0.000
Why?
RNA
1
1991
827
0.000
Why?
Pelak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)